Event

BCL-2 inhibitors synergistically enhance VSV oncolysis in primary chronic lymphocytic leukemia

Thursday, March 20, 2008 10:30
Duff Medical Building 3775 rue University, Montreal, QC, H3A 2B4, CA
Vanessa Tumilasci, PhD final seminar. Supervisor: Dr. Hiscott. Chair: Mayra Solis.
Back to top